195 related articles for article (PubMed ID: 35659905)
1. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Nagelkerke N; Coburn B; Cohen CR; Kaul R
Lancet Microbe; 2022 Jun; 3(6):e435-e442. PubMed ID: 35659905
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Cohen CR; Wierzbicki MR; French AL; Morris S; Newmann S; Reno H; Green L; Miller S; Powell J; Parks T; Hemmerling A
N Engl J Med; 2020 May; 382(20):1906-1915. PubMed ID: 32402161
[TBL] [Abstract][Full Text] [Related]
3. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
[TBL] [Abstract][Full Text] [Related]
4. Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact.
Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
Microbiome; 2024 Jun; 12(1):110. PubMed ID: 38907268
[TBL] [Abstract][Full Text] [Related]
5. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
6. Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Liu R; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
Microbiol Spectr; 2024 Jun; ():e0350123. PubMed ID: 38912808
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Liu R; Crawford ED; Castañeda GR; Nagelkerke N; Coburn B; Cohen CR; Kaul R
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35113809
[TBL] [Abstract][Full Text] [Related]
8. Safety, tolerability, and acceptability of
Bayar E; MacIntyre DA; Sykes L; Mountain K; Parks TP; Lee PP; Bennett PR
Benef Microbes; 2023 Mar; 14(1):45-56. PubMed ID: 36815494
[TBL] [Abstract][Full Text] [Related]
9. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
10. Orally administrated
Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
[TBL] [Abstract][Full Text] [Related]
12. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence.
Bohbot JM; Daraï E; Bretelle F; Brami G; Daniel C; Cardot JM
J Gynecol Obstet Hum Reprod; 2018 Feb; 47(2):81-86. PubMed ID: 29196153
[TBL] [Abstract][Full Text] [Related]
14.
Huang X; Lin R; Mao B; Tang X; Zhao J; Zhang Q; Cui S
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397477
[TBL] [Abstract][Full Text] [Related]
15. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug.
Lagenaur LA; Hemmerling A; Chiu C; Miller S; Lee PP; Cohen CR; Parks TP
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S296-S306. PubMed ID: 33330916
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
[TBL] [Abstract][Full Text] [Related]
17. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
18. Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial.
Bangar S; Sonar P; Mane A; Sane S; Kadam A; Katendra TL; Rahane G; Sinha A; Sahay S
Int J Infect Dis; 2023 Apr; 129():197-204. PubMed ID: 36773716
[TBL] [Abstract][Full Text] [Related]
19. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
[TBL] [Abstract][Full Text] [Related]
20. Association of
Ardizzone CM; Taylor CM; Toh E; Lillis RA; Elnaggar JH; Lammons JW; Mott PD; Duffy EL; Shen L; Quayle AJ
Front Cell Infect Microbiol; 2023; 13():1289449. PubMed ID: 38149008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
